SIG - Hot Stocks: GSK consumer unit; SIG makes buy; NKE analyst comment; NDAQ volume dip; RLAY offering

M&A headlines provided a key theme in Tuesday's pre-market trading. A host of private-equity firms are reportedly looking at GlaxoSmithKline's (NYSE:GSK) consumer unit. Meanwhile, Signet Jewelers (NYSE:SIG) rallied on a $490M purchase and raised guidance. In other news, Nike (NYSE:NKE) drew attention in pre-market trading as well. Shares rose after Goldman Sachs gave the stock an upbeat assessment. Looking at some of the pre-market losers, Nasdaq Inc. (NASDAQ:NDAQ) edged down on signs of a continued decline in U.S. equity-options volume. At the same time, Relay Therapeutics (NASDAQ:RLAY) lost a tenth of its value following the announcement of an equity offering. Gainers GlaxoSmithKline (GSK) received a lift in pre-market action amid reports that the company has received significant private-equity interest in its consumer unit. According to Bloomberg, several firms, including Blackstone, Carlyle and KKR, are evaluating a potential deal, which could value the division at $54B. Glaxo has previously said it

For further details see:

Hot Stocks: GSK consumer unit; SIG makes buy; NKE analyst comment; NDAQ volume dip; RLAY offering